Avosina Healthcare Solutions Data Breach Claims Investigated by Lynch Carpenter

PITTSBURGH, Pa., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Avosina Healthcare Solutions (“Avosina”), a medical billing company,1 recently announced a cybersecurity incident, which impacted the personal information of over forty thousand individuals. Lynch Carpenter, LLP is investigating claims against Avosina related to this data breach. For an attorney to review your case, visit our site HERE.

In the incident, an unauthorized person gained access to Avosina’s network and may have acquired records containing personally identifiable information (“PII”) and protected health information (“PHI”), including individuals’ names in combination with:

• address
• medical information, including medical procedures
• health insurance information, including account balances

If your information was impacted in this incident, you may be entitled to compensation. For an attorney to review your case, visit our site HERE.

If you have received any other data breach notice letters in the last 30 days, please contact us here.

About Lynch Carpenter

Lynch Carpenter is a national class action law firm with offices in Pennsylvania, California, and Illinois. Our firm has represented millions of clients in data privacy matters for more than a decade and has earned national acclaim for complex litigation for plaintiffs across the country. To learn more, please visit www.lynchcarpenter.com.

For more information, please call Jerry Wells at (412) 322-9243, or email him at [email protected].

CONTACT Jerry Wells
COMPANY Lynch Carpenter LLP
PHONE (412) 322-9243
EMAIL [email protected]
WEB lynchcarpenter.com

1 https://www.avosinamed.com/

You May Also Be Interested In

• Amended Notice of Secured Party Public Sale of Personal Property of XEVANT, INC.
• Crypto News Today: AlphaPepe Presale Nears $2.5M Raised as Bitcoin Price Prediction Targets $100,000
• CoreAgeRx Launches Advanced Preventive Longevity Protocols Featuring Microdosing Semaglutide, Microdosing Tirzepatide, and Sermorelin Therapies